Updated Jul 16, 2026
Thoma Jeanne has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.92M.

| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 4.4K | $0.00 | |
| 2025-08-18 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 14.7K | $88.87 | $1.30M |
| 2025-08-18 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 6.9K | $89.76 | $616K |
| 2025-05-22 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 4.3K | $0.00 | |
| 2024-12-17 | CDMO | Avid Bioservices, Inc. | M — Option exercise | 26.8K | — |
Thoma Jeanne is a corporate insider — currently tracked as Director of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.92M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thoma Jeanne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.